Brief Article
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2014; 20(5): 1305-1310
Published online Feb 7, 2014. doi: 10.3748/wjg.v20.i5.1305
Table 2 Relationship between antiapoptotic protein Bcl-xL and clinico-pathological parameters n (%)
VariablesBcl-xL expression
P value
WeakStrong
Age ≤ 603 (33.3)6 (66.7)0.853
> 6015 (36.6)26 (63.4)
GenderMale9 (37.5)15 (62.5)0.831
Female9 (34.6)17 (65.4)
LocalizationColon8 (28.6)20 (71.4)0.216
Rectum10 (45.5)12 (54.5)
Adenocarcinoma typeNon-mucinous16 (35.6)29 (64.4)0.844
Mucinous2 (40)3 (60)
pT stage22 (66.7)1 (33.3)0.253
316 (34)31 (66)
Lymph node metastasisAbsent8 (29.6)19 (70.4)0.309
Present10 (43.5)13 (56.5)
Distant metastasisAbsent14 (31.8)30 (68.2)0.095
Present4 (66.7)2 (33.3)
Lymphocytic infiltrationAbsent2 (40)3 (60)0.423
Weak8 (32)17 (68)
Moderate8 (47.1)9 (52.9)
Strong0 (0)3 (100)
Vascular invasionAbsent10 (43.5)13 (56.5)0.309
Present8 (29.6)19 (70.4)
Tumor buddingAbsent5 (45.4)6 (54.5)0.459
Present13 (33.3)26 (66.7)